124
Views
17
CrossRef citations to date
0
Altmetric
Review

Obesity and the dysregulation of fatty acid metabolism: implications for healthy aging

, &
Pages 501-510 | Received 13 Jun 2016, Accepted 03 Oct 2016, Published online: 17 Oct 2016

References

  • United Nations, Department of Economic and Social Affairs, Population Division; 2015. World Population Ageing 2015. ST/ESA/SER.A/390
  • In: aging and the macroeconomy: long-term implications of an older population. National Academies Press: Washington (DC); 2012.
  • WHO. Obesity and overweight: fact sheet no 311. Eds. World Health Organisation; 2015.
  • Health Survey for England, 2014 [NS] 2015. Avilable from: http://www.hscic.gov.uk/catalogue/PUB19295).
  • Health Survey for England, 2014. http://www.hscic.gov.uk/catalogue/PUB19295 (2015).
  • Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment–a position paper of the the obesity society and The American society of hypertension. Obesity (Silver Spring). 2013;21(1):8–24.
  • Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81–87.
  • Boden G, Salehi S. Why does obesity increase the risk for cardiovascular disease? Curr Pharm Des. 2013;19(32):5678–5683.
  • Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–1083.
  • Crowson CS, Matteson EL, Davis JM 3rd, et al. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res. 2013;65(1):71–77.
  • Qizilbash N, Gregson J, Johnson ME, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. The Lancet. Diabetes & Endocrinology. 2015;3(6):431–436.
  • Ligibel JA, Strickler HD. Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educational Book /ASCO. Am Soc Clin Oncology Meet. 2013;33:52–59.
  • Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62(6):933–947.
  • Chen Q, Zhuang H, Liu Y. The association between obesity factor and esophageal caner. J Gastrointest Oncol. 2012;3(3):226–231.
  • Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog. 2012;51(1):53–63.
  • Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45(16):2867–2873.
  • Frayn KN, Arner P, Yki-Jarvinen H. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays Biochem. 2006;42:89–103.
  • Lafontan M. Adipose tissue and adipocyte dysregulation. Diabetes Metab. 2014;40(1):16–28.
  • Gonçalves CG, Glade MJ, Meguid MM. Metabolically healthy obese individuals: Key protective factors. Nutrition. 2016;32(1):14–20.
  • Mittendorfer B. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Curr Opin Clin Nutr Metab Care. 2011;14(6):535–541.
  • Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24.
  • Morgan AE, Mooney KM, Wilkinson SJ, et al. Cholesterol metabolism: A review of how ageing disrupts the biological mechanisms responsible for its regulation. Ageing Res Rev. 2016;27:108–124.
  • Mooney KM, Mc Auley MT. Cardiovascular disease and healthy ageing. J Integr Cardiol. 2015;1(4):76–78.
  • Fuke Y, Okabe S, Kajiwara N, et al. Increase of visceral fat area in Indonesians and Japanese with normal BMI. Diabetes Res Clin Pract. 2007;77(Suppl 1):S224–227.
  • Kuk JL, Saunders TJ, Davidson LE, et al. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8(4):339–348.
  • Mueller WH. The changes with age of the anatomical distribution of fat. Soc Sci Med. 1982;16(2):191–196.
  • Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord. 1994;18(4):207–202.
  • Pararasa C, Ikwuobe J, Shigdar S, et al. Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell. 2016;15(1):128–139.
  • Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761.
  • Sanz A, Stefanatos RK. The mitochondrial free radical theory of aging: a critical view. Curr Aging Sci. 2008;1(1):10–21.
  • Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. 1972;20(4):145–147.
  • Barja G. Aging in vertebrates, and the effect of caloric restriction: a mitochondrial free radical production-DNA damage mechanism? Biol Rev Camb Philos Soc. 2004;79(2):235–251.
  • Corcoran MP, Lamon-Fava S, Fielding RA. Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr. 2007;85(3):662–677.
  • Hollander D, Morgan D. Increase in cholesterol intestinal absorption with aging in the rat. Exp Gerontol. 1979;14(4):201–204.
  • The Lipid Research Clinics’ Population Studies Data Book. US dept of health and human services. Washington, DC: National Institutes of Health; 1980.
  • Soardo G, Donnini D, Domenis L, et al. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord. 2011;9(5):397–401.
  • Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. Journals Gerontol Ser A: Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9.
  • Baylis D, Bartlett DB, Patel HP, et al. Understanding how we age: insights into inflammaging. Longevity & Healthspan. 2013;2(1):1–8.
  • Stepanova M, Rodriguez E, Birerdinc A, et al. Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity. Oncotarget. 2015;6(3):1414–1421.
  • Kang YE, Kim JM, Joung KH, et al. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS ONE. 2016;11(4):e0154003.
  • Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19(4):972–978.
  • Alessi MC, Bastelica D, Morange P, et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 2000;49(8):1374–1380.
  • Balagopal P, Sweeten S, Mauras N. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol Endocrinol Metab. 2002;282(4):E899–904.
  • Zhao LF, Iwasaki Y, Zhe W, et al. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocr J. 2010;57(4):317–324.
  • Elizalde M, Ryden M, van Harmelen V, et al. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res. 2000;41(8):1244–1251.
  • Oh DY, Morinaga H, Talukdar S, et al. Increased macrophage migration into adipose tissue in obese mice. Diabetes. 2012;61(2):346–354.
  • Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proc Natl Acad Sci. 2009;106(35):14978–14983.
  • Prieur X, Mok CYL, Velagapudi VR, et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 2011;60(3):797–809.
  • Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage M1–M2 polarization balance. Front Immunol. 2014;5:614.
  • Nieto-Vazquez I, Fernandez-Veledo S, Kramer DK, et al. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008;114(3):183–194.
  • Zhang HH, Halbleib M, Ahmad F, et al. Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes. 2002;51(10):2929–2935.
  • Greenberg AS, Shen WJ, Muliro K, et al. Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem. 2001;276(48):45456–45461.
  • Xu H, Sethi JK, Hotamisligil GS. Transmembrane Tumor Necrosis Factor (TNF)-α inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem. 1999;274(37):26287–26295.
  • Anusree SS, Nisha VM, Priyanka A, et al. Insulin resistance by TNF-α is associated with mitochondrial dysfunction in 3T3-L1 adipocytes and is ameliorated by punicic acid, a PPARγ agonist. Mol Cell Endocrinol. 2015;413:120–128.
  • Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004;80(4):1029–1035.
  • Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. Jama. 2003;289(14):1799–1804.
  • Bashir S, Sharma Y, Elahi A, et al. Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation. J Nutr Biochem. 2016;33:82–90.
  • Gironés-Vilaplana A, Baenas N, Villaño D, et al. Evaluation of Latin-American fruits rich in phytochemicals with biological effects. J Funct Foods. 2014;7:599–608.
  • Aron-Wisnewsky J, Tordjman J, Poitou C, et al. Human adipose tissue macrophages: M1 and M2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metabolism. 2009;94(11):4619–4623.
  • Mc Auley MT, Mooney KM. Lipid metabolism and hormonal interactions: impact on cardiovascular disease and healthy aging. Expert Rev Endocrinol Metab. 2014;9(4):357–367.
  • Choi SM, Tucker DF, Gross DN, et al. Insulin regulates adipocyte lipolysis via an akt-independent signaling pathway. Mol Cell Biol. 2010;30(21):5009–5020.
  • Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13(6):383–396.
  • Liljenquist JE, Bomboy JD, Lewis SB, et al. Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. J Clin Investig. 1974;53(1):190–197.
  • Zjacic-Rotkvic V, Kavur L, Cigrovski-Berkovic M. Hormones and aging. Acta Clin Croat. 2010;49(4):549–554.
  • Mabrouk GM, Helmy IM, Thampy KG, et al. Acute hormonal control of acetyl-CoA carboxylase. The roles of insulin, glucagon, and epinephrine. J Biol Chem. 1990;265(11):6330–6338.
  • Tsujimoto A, Tsujimoto G, Hoffman BB. Age-related change in adrenergic regulation of glycogen phosphorylase in rat hepatocytes. Mech Ageing Dev. 1986;33(2):167–175.
  • Langin D, Dicker A, Tavernier G, et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes. 2005;54(11):3190–3197.
  • Degerman E, Landstrom TR, Wijkander J, et al. Phosphorylation and activation of hormone-sensitive adipocyte phosphodiesterase type 3B. Methods. 1998;14(1):43–53.
  • Slavin BG, Ong JM, Kern PA. Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 1994;35(9):1535–1541.
  • Yost TJ, Jensen DR, Haugen BR, et al. Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects. Am J Clin Nutr. 1998;68(2):296–302.
  • Kiens B, Lithell H, Mikines KJ, et al. Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action. J Clin Invest. 1989;84(4):1124–1129.
  • Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. J Clin Invest. 1982;69(5):1119–1125.
  • Borensztajn J, Keig P, Rubenstein AH. The role of glucagon in the regulation of myocardial lipoprotein lipase activity. Biochem Biophys Res Commun. 1973;53(2):603–608.
  • Caren R, Corbo L. Glucagon and plasma lipoprotein lipase. Proc Soc Exp Biol Med. 1974;146(4):1106–1110.
  • Murase T, Tanaka K, Iwamoto Y, et al. Reciprocal changes, caused by insulin and glucagon, of adipose tissue lipoprotein lipase in rats in vitro. Horm Metab Res. 1981;13(4):212–213.
  • Ricart-Jane D, Cejudo-Martin P, Peinado-Onsurbe J, et al. Changes in lipoprotein lipase modulate tissue energy supply during stress. J Appl Physiol. 2005;99(4):1343–1351.
  • Oscarsson J, Ottosson M, Vikman-Adolfsson K, et al. GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J Endocrinol. 1999;160(2):247–255.
  • Surwit RS, Williams RB, Lane JD, et al. Plasma epinephrine predicts fasting glucose in centrally obese African-American women. Obesity. 2010;18(9):1683–1687.
  • Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord. 1999;23(3):260–271.
  • Elahi D, Muller DC, Tzankoff SP, et al. Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man. J Gerontol. 1982;37(4):385–391.
  • Rudman D, Kutner MH, Rogers CM, et al. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 1981;67(5):1361–1369.
  • Esler M, Kaye D, Thompson J, et al. Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. J Clin Endocrinol Metab. 1995;80(2):435–442.
  • Bey L, Areiqat E, Sano A, et al. Reduced lipoprotein lipase activity in postural skeletal muscle during aging. J Appl Physiol. 2001;91(2):687–692.
  • Brodows RG, Campbell RG. Effect of age on post-heparin lipase. N Engl J Med. 1972;287(19):969–970.
  • Bey L, Hamilton MT. Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low-intensity activity. J Physiol. 2003;551(Pt 2):673–682.
  • McAuley MT, Kenny RA, Kirkwood TB, et al. A mathematical model of aging-related and cortisol induced hippocampal dysfunction. BMC Neurosci. 2009;10:26.
  • Rask E, Walker BR, Söderberg S, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metabolism. 2002;87(7):3330–3336.
  • Roelfsema F, Pijl H, Keenan DM, et al. Diminished adrenal sensitivity and ACTH efficacy in obese premenopausal women. Eur J Endocrinol. 2012;167(5):633–642.
  • Pasquali R, Ambrosi B, Armanini D, et al. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab. 2002;87(1):166–175.
  • Stomby A, Andrew R, Walker BR, et al. Tissue-specific dysregulation of cortisol regeneration by 11betaHSD1 in obesity: has it promised too much? Diabetologia. 2014;57(6):1100–1110.
  • Lanfranco F, Giordano R, Pellegrino M, et al. Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans. J Clin Endocrinol Metabolism. 2004;89(3):1385–1390.
  • Lanfranco F, Gianotti L, Picu A, et al. Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa. Eur J Endocrinol. 2006;154(5):731–738.
  • Katoh K, Asari M, Ishiwata H, et al. Saturated fatty acids suppress adrenocorticotropic hormone (ACTH) release from rat anterior pituitary cells in vitro. Comp Biochemistry Physiol A: Mol Integr Physiol. 2004;137(2):357–364.
  • Arad Y, Pollack S, Roth M, et al. Adrenal cortisol hyper-responsiveness as a possible cause of obesity, insulin resistance and cardiovascular risk. J Diabetes Metab. 2015;6:10.
  • Parker CR Jr., Slayden SM, Azziz R, et al. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab. 2000;85(1):48–54.
  • Koutsari C, Ali AH, Nair KS, et al. Fatty acid metabolism in the elderly: effects of dehydroepiandrosterone and testosterone replacement in hormonally deficient men and women. J Clin Endocrinol Metab. 2009;94(9):3414–3423.
  • Amouzou C, Breuker C, Fabre O, et al. Skeletal muscle insulin resistance and absence of inflammation characterize insulin-resistant grade i obese women. PLoS One. 2016;11(4):e0154119.
  • Guerra B, Fuentes T, Delgado-Guerra S, et al. Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS ONE. 2008;3(10):e3466.
  • Carter S, Caron A, Richard D, et al. Role of leptin resistance in the development of obesity in older patients. Clin Interv Aging. 2013;8:829–844.
  • Huby A-C, Antonova G, Groenendyk J, et al. Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation. 2015;132(22):2134–2145.
  • Liu Q, Yuan B, Lo KA, et al. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc Natl Acad Sci. 2012;109(36):14568–14573.
  • Kim AY, Park YJ, Pan X, et al. Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nat Commun. 2015;6:7585.
  • Okada-Iwabu M, Yamauchi T, Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature. 2013;503(7477):493–499.
  • Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941–946.
  • Mc Auley MT, Mooney KM. Computationally modeling lipid metabolism and aging: a mini-review. Comput Struct Biotechnol J. 2015;13:38–46.
  • Mc Auley MT, Proctor CJ, Corfe BM, et al. Nutrition research and the impact of computational systems biology. J Comput Sci Syst Biol. 2013;6:271–285.
  • Mc Auley MT, Mooney KM. Computational systems biology for aging research. Interdiscip Top Gerontol. 2015;40:35–48.
  • Mc Auley MT, Mooney KM, Angell PJ, et al. Mathematical modelling of metabolic regulation in aging. Metabolites 2015. 2015;5(2):232–251.
  • Mc Auley MM, Wilkinson DJ, Jones JJ, et al. A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation. BMC Syst Biol. 2012;6(1):130.
  • Morgan AE, Mooney KM, Wilkinson SJ, et al. Mathematically modelling the dynamics of cholesterol metabolism and ageing. Biosystems. 2016;145:19–32.
  • Mc Auley M, Jones J, Wilkinson D, et al. Modelling lipid metabolism to improve healthy ageing. BMC Bioinformatics. 2005;6(3):1–1.
  • Kilner J, Corfe BM, McAuley MT, et al. A deterministic oscillatory model of microtubule growth and shrinkage for differential actions of short chain fatty acids. Mol Biosyst. 2016;12(1):93–101.
  • Kim J, Saidel GM, Kalhan SC. A computational model of adipose tissue metabolism: evidence for intracellular compartmentation and differential activation of lipases. J Theor Biol. 2008;251(3):523–540.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.